Serum circulating miRNA‐342‐3p as a potential diagnostic biomarker in parathyroid carcinomas: A pilot study-Reference-Cited by-同舟云学术

Serum circulating miRNA‐342‐3p as a potential diagnostic biomarker in parathyroid carcinomas: A pilot study

Published:2021-07-29 Issue:4 Volume:4 Page:
ISSN:2398-9238
Container-title:Endocrinology, Diabetes & Metabolism
language:en
Short-container-title:Endocrino Diabet & Metabol

Author:

Krupinova Julia¹^ORCID,Mokrysheva Natalya¹,Petrov Vasiliy¹,Pigarova Ekaterina¹,Eremkina Anna¹^ORCID,Dobreva Ekaterina¹,Ajnetdinova Alina¹,Melnichenko Galina¹,Tiulpakov Anatoly¹

Affiliation:

1. Endocrinology Research Center Moscow Russia

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/edm2.284

Reference37 articles.

1. Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985-1995

2. Trends in the incidence and treatment of parathyroid cancer in the United States

3. Parathyroid carcinoma: increasing incidence and changing presentation

4. Localization and Reoperation Results for Persistent and Recurrent Parathyroid Carcinoma

5. Parathyroid Carcinoma: An Update on Treatment Outcomes and Prognostic Factors from the National Cancer Data Base (NCDB)

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating non-coding RNA biomarkers of endocrine tumours;Nature Reviews Endocrinology;2024-06-17

2. Detection and identification of circulating tumor cells in parathyroid tumors and correlation analysis with clinicopathological features;Endocrine;2024-05-10

3. Exosomal miR‐122, miR‐128, miR‐200, miR‐298, and miR‐342 as novel diagnostic biomarkers in NAFL/NASH: Impact of LPS/TLR‐4/FoxO3 pathway;Archiv der Pharmazie;2024-01-22

4. Primary hyperparathyroidism in children;Problems of Endocrinology;2023-10-15

5. Parathyroid carcinoma: molecular therapeutic targets;Endocrine;2023-05-09